Cardiovascular Systems Inc  

(Public, NASDAQ:CSII)   Watch this stock  
Find more results for Robert Bartos
9.09
-0.67 (-6.86%)
Feb 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.07 - 9.88
52 week 8.02 - 41.28
Open 9.72
Vol / Avg. 281,715.00/669,553.00
Mkt cap 276.81M
P/E     -
Div/yield     -
EPS -1.49
Shares 32.70M
Beta 1.17
Inst. own 83%
Apr 27, 2016
Q3 2016 Cardiovascular Systems Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 10, 2016
Cardiovascular Systems Inc at Leerink Partners Global Healthcare Conference - 2:40PM EST - Add to calendar
Jan 21, 2016
Q2 2016 Cardiovascular Systems Inc Earnings Call - Webcast
Jan 21, 2016
Q2 2016 Cardiovascular Systems Inc Earnings Release
Nov 18, 2015
Cardiovascular Systems Inc Annual Shareholders Meeting
Nov 12, 2015
Cardiovascular Systems Inc Annual Shareholders Meeting (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -36.63% -18.08%
Operating margin -36.58% -17.98%
EBITD margin - -16.70%
Return on average assets -38.79% -18.58%
Return on average equity -48.29% -22.52%
Employees 597 -
CDP Score - -

Address

1225 Old Highway 8 NW
ST. PAUL, MN 55112-6416
United States - Map
+1-651-2591600 (Phone)
+1-612-6773355 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee. Its products include Stealth 360 degree Peripheral Orbital Atherectomy System (OAS); the Diamondback 360 Peripheral OAS (Diamondback 360 Peripheral), and Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral OAS and Diamondback 360 4 French 1.25 Peripheral (collectively called as peripheral arterial disease systems (PAD systems)). Its coronary product, the Diamondback 360 Coronary OAS (CAD System), is a catheter-based platform designed to facilitate stent delivery in patients with coronary arterial disease (CAD). The CAD System design is customized for the coronary application.

Officers and directors

Scott R. Ward Chairman of the Board, Interim Chief Executive Officer, President
Age: 56
Bio & Compensation  - Reuters
Laurence L. Betterley Chief Financial Officer
Age: 61
Bio & Compensation  - Reuters
Kevin J. Kenny Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Paul Koehn Senior Vice President - Quality and Operations
Age: 52
Bio & Compensation  - Reuters
Robert J. Thatcher Chief Healthcare Policy Officer
Age: 60
Bio & Compensation  - Reuters
Scott A. Bartos Independent Director
Age: 52
Bio & Compensation  - Reuters
Brent G. Blackey Independent Director
Age: 56
Bio & Compensation  - Reuters
Edward M. Brown Independent Director
Age: 52
Bio & Compensation  - Reuters
William E. Cohn M.D. Independent Director
Age: 55
Bio & Compensation  - Reuters
Augustine J. Lawlor Independent Director
Age: 59
Bio & Compensation  - Reuters